Amifostine protects against chemotherapy-induced neurotoxicity: An In vitro investigationVERSTAPPEN, Carla C. P; POSTMA, Tjeerd J; GELDOF, Albert A et al.Anticancer research. 2004, Vol 24, Num 4, pp 2337-2341, issn 0250-7005, 5 p.Article

Amifostine: Is there evidence of tumor protection?KOUKOURAKIS, Michael I.Seminars in oncology. 2003, Vol 30, Num 6, pp 18-30, issn 0093-7754, 13 p., SUP18Conference Paper

Efficacy and tolerability of amifostine in elderly cancer patients. CommentaryBARUTCA, Sabri; MEYDAN, Nezih; AKAR, Harun et al.Current therapeutic research. 2004, Vol 65, Num 1, issn 0011-393X, 112,113-124 [13 p.]Article

Individualization of the subcutaneous amifostine dose during hypofractionated / accelerated radiotherapyKOUKOURAKIS, Michael I; ABATZOGLOU, Ioannis; SIVRIDIS, Leonidas et al.Anticancer research. 2006, Vol 26, Num 3B, pp 2437-2443, issn 0250-7005, 7 p.Article

A comparison of the action of amifostine and melatonin on DNA- damaging effects and apoptosis induced by idarubicin in normal and cancer cellsMAJSTEREK, Ireneusz; GLOC, Ewa; BLASIAK, Janusz et al.Journal of pineal research. 2005, Vol 38, Num 4, pp 254-263, issn 0742-3098, 10 p.Article

Prevention of radiation-induced central nervous system toxicity: A role for amifostine?NIEDER, Carsten; ANDRATSCHKE, Nicolaus H; WIEDENMANN, Nicole et al.Anticancer research. 2004, Vol 24, Num 6, pp 3803-3809, issn 0250-7005, 7 p.Article

Myeloprotective effects of different amifostine regimens in rabbits undergoing high-dose treatment with ¹⁸⁶rhenium-(tin)1,1-hydroxyethylidene diphosphonate (¹⁸⁶Re-HEDP)BRENNER, Winfried; KAMPEN, Willm Uwe; BRÜMMER, Corinna et al.Cancer biotherapy & radiopharmaceuticals. 2003, Vol 18, Num 6, pp 887-893, issn 1084-9785, 7 p.Article

In vivo study to evaluate the protective effects of amifostine on radiation- induced damage of testis tissueANDRIEU, Meltem Nalca; KURTMAN, Cengiz; HICSONMEZ, Ayse et al.Oncology. 2005, Vol 69, Num 1, pp 44-51, issn 0030-2414, 8 p.Article

Effect of Amifostine on Survival Among Patients Treated With Radiotherapy: A Meta-Analysis of Individual Patient DataBOURHIS, Jean; BLANCHARD, Pierre; PIGNON, Jean Pierre et al.Journal of clinical oncology. 2011, Vol 29, Num 18, pp 2590-2597, issn 0732-183X, 8 p.Article

Ongoing prospective multicenter safety study of the cytoprotectant amifostine given subcutaneously: Overview of trial designSAMUELS, Michael A; CHICO, Isagani M; HIRSCH, Robert L et al.Seminars in oncology. 2003, Vol 30, Num 6, pp 94-95, issn 0093-7754, 2 p., SUP18Conference Paper

Amifostine in the treatment of patients with myelodysplastic syndromeLARSEN, S. R; MANOHARAN, A.Australian and New Zealand journal of medicine. 1999, Vol 29, Num 5, pp 753-754, issn 0004-8291Article

Randomized trials of amifostine and radiotherapy : Effect on survival?BOURHIS, J; THEPHAMONGKHOL, K; PIGNON, J. P et al.Seminars in oncology. 2004, Vol 31, Num 6, pp 62-66, issn 0093-7754, 5 p., SUP18Conference Paper

Radioprotection of Osteoblasts by a Fractionated Dose Regimen and AmifostineWONG, Alex K; MEI, Lily; SOARES, Marc A et al.Plastic and reconstructive surgery (1963). 2009, Vol 123, Num 2S, issn 0032-1052, 104S-113S, SUPConference Paper

Feasibility of amifostine administration in conjunction with high-dose rate brachytherapyDZIUK, Timothy; SENZER, Neil.Seminars in oncology. 2003, Vol 30, Num 6, pp 49-57, issn 0093-7754, 9 p., SUP18Conference Paper

Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: Results of A randomized trialATHANASSIOU, Helen; ANTONADOU, Dosia; THROUVALAS, Nicolas et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 4, pp 1154-1160, issn 0360-3016, 7 p.Article

The relationship between local dose and loss of function for irradiated lungGOPAL, Ramesh; TUCKER, Susan L; KOMAKI, Ritsuko et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 1, pp 106-113, issn 0360-3016, 8 p.Article

Radioprotectants: Current status and new directionsGRDINA, David J; MURLEY, Jeffrey S; KATAOKA, Yasushi et al.Oncology. 2002, Vol 63, pp 2-10, issn 0030-2414, 9 p., SUP2Conference Paper

A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantationHWANG, W. Y. K; KOH, L.-P; GOH, Y.-T et al.Bone marrow transplantation (Basingstoke). 2004, Vol 34, Num 1, pp 51-56, issn 0268-3369, 6 p.Article

Amifostine Protection Against Induced DNA Damage in γ-irradiated Escherichia coli Cells Depend on recN DNA Repair Gene Product ActivityALMEIDA, Eliseo; FUENTES, Jorge Luis; CUETARA, Elizabeth et al.Environmental toxicology. 2010, Vol 25, Num 2, pp 130-136, issn 1520-4081, 7 p.Article

Disposition of WR-1065 in the liver of tumor-bearing rats following regional vs systemic administration of amifostineLEVI, Micha; DEREMER, Susan J; CHUNZHI DOU et al.Biopharmaceutics & drug disposition. 2004, Vol 25, Num 1, pp 27-35, issn 0142-2782, 9 p.Article

Oxidative study of patients with total body irradiation: effects of amifostine treatmentFACORRO, G; SARRASAGUE, M. M; TORTI, H et al.Bone marrow transplantation (Basingstoke). 2004, Vol 33, Num 8, pp 793-798, issn 0268-3369, 6 p.Article

Amifostine for children with medulloblastoma treated with cisplatin-based chemotherapyFISHER, Michael J; LANGE, Beverly J; NEEDLE, Michael N et al.Pediatric blood & cancer. 2004, Vol 43, Num 7, pp 780-784, issn 1545-5009, 5 p.Article

Antimutagenicity of amifostine against the anticancer drug fotemustine in the Drosophila somatic mutation and recombination (SMART) testAYDEMIR, N; SEVIM, N; CELIKLER, S et al.Mutation research. Genetic toxicology and environmental mutagenesis (Print). 2009, Vol 679, Num 1-2, pp 1-5, issn 1383-5718, 5 p.Article

Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancerTHORSTAD, Wade L; CLIFFORD CHAO, K. S; HAUGHEY, Bruce et al.Seminars in oncology. 2004, Vol 31, Num 6, pp 8-12, issn 0093-7754, 5 p., SUP18Conference Paper

Toxicity profile of intensity-modulated radiation therapy for head and neck carcinoma and potential role of amifostineCLIFFORD CHAO, K. S; OZYIGIT, Gokhan; THORSDAD, Wade L et al.Seminars in oncology. 2003, Vol 30, Num 6, pp 101-108, issn 0093-7754, 8 p., SUP18Conference Paper